Milk thistle phospholipid complex, preparation method thereof and application in reducing liver damage

Through the combination of silylb extract, dihydrobaumen and phospholipids, the problem of low bioavailability is solved, more efficient liver protection effect and production efficiency are achieved, production costs are reduced, liver cells are jointly protected and hangovers are reduced Discomfort.

CN116270781BActive Publication Date: 2024-11-08NANJING AURORA BOREALIS BIOTECHNOLOGY CO LTD
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202211476964.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-11-23
Publication Date
2024-11-08
Estimated Expiration
2042-11-23

AI Technical Summary

Technical Problem

The bioavailability of silybin and dihydrobamate is low, and the existing liposome preparation process has problems such as large organic solvent usage, long reaction time and high production cost.

Method used

The silylb extract, dihydrobaumen and phospholipid are combined in an organic solvent. By drying under reduced pressure and hydrating in a phosphate buffer water bath, the obtained silylb phospholipid complex has improved bioavailability and reduced production costs. effect.

Benefits of technology

Shorten the reaction time, improve bioavailability and production efficiency, reduce production costs, and enhance liver protection effects, coordinately protect liver cells and reduce hangover discomfort.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0003959639250000081
    Figure BDA0003959639250000081
  • Figure BDA0003959639250000091
    Figure BDA0003959639250000091
  • Figure BDA0003959639250000092
    Figure BDA0003959639250000092
Patent Text Reader

Abstract

The invention discloses a silymarin phospholipid complex and a preparation method thereof and an application thereof in reducing liver damage. The preparation method of the silymarin phospholipid complex comprises: step 1: dissolving silymarin extract, dihydromyricetin and phospholipid in an organic solvent. Step 2: stirring the solution system until the solution is clarified; step 3: drying the clarified solution under reduced pressure, then crushing and sieving to obtain a solid powder; the content of silybin is 20%-40%, and the content of dihydromyricetin is 15%-20%. The two synergistically protect the liver, and the efficacy is significantly enhanced; and the addition of dihydromyricetin reduces the reaction time and temperature to a certain extent, reduces the production energy consumption, increases the utilization rate of the organic solvent, and simplifies the process, thereby reducing the production cost.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a milk thistle complex, in particular to a milk thistle phospholipid complex and application thereof in protecting the liver and reducing liver damage. Background Art

[0002] With the development of society, people's lifestyles have also changed a lot. Staying up late, drinking alcohol for social events, and eating takeout for midnight snacks have become a daily routine. Irregular work and rest schedules and diets increase the burden on the liver and threaten the body's immune system. Liver health has also attracted the attention of mass consumers and researchers. Plant extracts such as milk thistle, artichoke, sesame, dihydromyricetin, and some probiotics involving the liver-gut axis are becoming more and more well-known.

[0003] Silybin is an antioxidant mainly extracted from milk thistle seeds. After entering the body, it acts on the liver, increasing the content of SOD and glutathione peroxidase, reducing the level of malondialdehyde (MDA), helping the liver to scavenge free radicals, and protecting liver cells from damage. At the same time, it binds to exogenous pathogens to help the liver detoxify and reduce the liver's detoxification pressure. However, due to poor solubility, its bioavailability in organisms is not high. Although silybin meglumine is currently on the market, which increases the water solubility of silybin by modifying the molecular structure, its poor oil solubility also greatly limits its utilization in the body. Xiao Yanyu and other scholars used an organic solvent method to compound silybin and phospholipids, and the resulting product had greatly improved fat solubility and water solubility. Compared with milk thistle extract, the bioavailability was significantly improved.

[0004] Dihydromyricetin belongs to the flavonoids and is abundant in the stems and leaves of the plant Agave sphenanthera. Studies have shown that it can improve liver lipid metabolism by reducing the NADPH / NAD+ ratio. Other studies have shown that dihydromyricetin can repair mitochondrial function damaged by acetaldehyde toxicity, reduce the production of ROS by controlling the AMPK / Sirt-1 / PGC-1α pathway, thereby inhibiting oxidative stress and improving the corresponding ALD, which helps protect the liver. However, its low bioavailability is also the biggest limiting factor affecting its application.

[0005] In summary, silybin and dihydromyricetin have the common feature of low bioavailability, while the preparation process of liposomes has problems such as large amount of organic solvents, long reaction time and high production cost. Summary of the invention

[0006] The object of the present invention is to provide a method for preparing a silymarin phospholipid complex in view of the deficiencies of the prior art, comprising:

[0007] Step 1: Milk thistle extract, dihydromyricetin and phospholipids are dissolved in an organic solvent.

[0008] Step 2: Stir the solution system until the solution becomes clear.

[0009] Step 3: drying the clear solution under reduced pressure, and then adding phosphate buffer as a hydration medium for hydration in a water bath;

[0010] Step 4: Dry, crush and sieve to obtain solid powder.

[0011] Furthermore, the obtained product is in the form of uniform white or light yellow solid powder.

[0012] Furthermore, the raw materials include 5-10 parts of milk thistle extract, 1-6 parts of dihydromyricetin, and 10-20 parts of phospholipids.

[0013] Furthermore, the organic solvent is one or a combination of two or more of ethanol, methanol, ethyl acetate, acetone, and chloroform.

[0014] Furthermore, the amount of solvent is at least 5 times the total mass of the raw materials; for example, 6 times, 9 times, 10 times, 20 times, etc.

[0015] Further, the reduced pressure drying temperature is 20-70°C, further, the reduced pressure drying temperature is 30-60°C, further, the reduced pressure drying temperature is 45°C.

[0016] Furthermore, the stirring temperature is 20-80°C.

[0017] Further, the membrane is washed with phosphate buffer as a hydration medium to obtain a milky translucent liposome solution, and then freeze-dried or spray-dried. For example, the membrane washing conditions are hydration in a constant temperature water bath at 40°C for 2 hours and water bath ultrasound for 30 minutes.

[0018] Furthermore, the obtained product is in the form of uniform white or light yellow solid powder.

[0019] Further, the content of silybin is 2%-60%, and the content of dihydromyricetin is 2%-40%; preferably, the content of silybin is 20%-40%, and the content of dihydromyricetin is 15%-20%.

[0020] Further, step 5: pack and seal, and place in a cool and dry place.

[0021] The invention also provides a silybin phospholipid complex, comprising silybin, dihydromyricetin and phospholipid, wherein the content of silybin is 2%-60%, and the content of dihydromyricetin is 2%-40%.

[0022] Furthermore, the content of silybin is 20%-40%, and the content of dihydromyricetin is 15%-20%.

[0023] Further, the preparation method of the composite is:

[0024] Step 1: Milk thistle extract, dihydromyricetin and phospholipids are dissolved in an organic solvent.

[0025] Step 2: Stir the solution system until the solution becomes clear.

[0026] Step 3: drying the clear solution under reduced pressure, and then adding phosphate buffer as a hydration medium for hydration in a water bath;

[0027] Step 4: Dry, crush and sieve to obtain solid powder.

[0028] Furthermore, the raw materials include 5-10 parts of milk thistle extract, 1-6 parts of dihydromyricetin, and 10-20 parts of phospholipids.

[0029] The present invention also provides an application of the milk thistle phospholipid complex in the preparation of liver injury medicines, health foods, dietary supplements and foods. Further, the above phospholipid complex is used.

[0030] The present invention also provides an application of the milk thistle phospholipid complex in the preparation of liver protection medicines, health foods, dietary supplements and foods. Further, the above phospholipid complex is used.

[0031] Beneficial effects: When silybin and phospholipids are compounded in an organic solvent, adding an appropriate amount of dihydromyricetin can shorten the reaction time and obtain a phospholipid complex containing two or more flavonoids more quickly. First, from the perspective of bioavailability, the combination of phospholipids, silybin and dihydromyricetin to form a phospholipid complex product greatly improves the bioavailability of the two; secondly, from the perspective of liver protection, silybin can increase the levels of SOD and glutathione peroxidase and protect liver cells, while dihydromyricetin can improve liver lipid metabolism by reducing the NADPH / NAD+ ratio and the amount of triglycerides. At the same time, it can increase the expression of hippocampal and neuronal GABAARs a4 subunits, reduce hangover discomfort, and shorten the sobering time; that is, silybin and dihydromyricetin can protect liver cells through anti-oxidation, the former helps detoxification, and the latter helps sobering up. The two work together to protect the liver, and the efficacy is significantly enhanced.

[0032] From a technological perspective, the addition of dihydromyricetin can reduce reaction time and temperature to a certain extent, reduce production energy consumption, increase the utilization rate of organic solvents, and simplify the process, thereby reducing production costs. DETAILED DESCRIPTION

[0033] In order to facilitate the understanding of those skilled in the art, the present invention is further described below in conjunction with embodiments, and the contents mentioned in the implementation modes are not intended to limit the present invention.

[0034] Example 1

[0035] A method for preparing a milk thistle phospholipid complex comprises:

[0036] Step 1. Place 10 g silybin, 17 g phospholipids, 6 g dihydromyricetin and 300 ml anhydrous ethanol in a round-bottom flask.

[0037] Step 2. Mix and react at a certain temperature until the solution is clear.

[0038] Step 3. Dry the clarified solution under reduced pressure, then add 500 mL of phosphate buffered saline (PBS) as a hydration medium to wash the membrane, hydrate in a constant temperature water bath at 40°C for 2 h, and perform water bath ultrasound for 30 min to obtain a milky translucent liposome solution, followed by freeze drying.

[0039] Step 4: Grind and sieve 80 mesh, and package to obtain a powdered ingredient.

[0040] Example 2

[0041] A method for preparing a milk thistle phospholipid complex comprises:

[0042] Step 1. 10 g silybin, 17 g phospholipids, 6 g dihydromyricetin and 600 ml ethyl acetate were placed in a round bottom flask.

[0043] Step 2. Mix and react at a certain temperature until the solution is clear.

[0044] Step 3. Dry the clarified solution under reduced pressure, then add 500 mL of phosphate buffered saline (PBS) as a hydration medium to wash the membrane, hydrate in a constant temperature water bath at 40°C for 2 h, and perform water bath ultrasound for 30 min to obtain a milky translucent liposome solution, followed by spray drying.

[0045] Step 4: Grind and sieve 100 mesh, and package to obtain a powdered ingredient.

[0046] Example 3

[0047] A method for preparing a milk thistle phospholipid complex comprises:

[0048] Step 1: dissolving milk thistle extract, dihydromyricetin and phospholipids in an organic solvent;

[0049] Step 2: Stir the solution system until the solution becomes clear;

[0050] Step 3: drying the clear solution under reduced pressure, and then adding phosphate buffer as a hydration medium for hydration in a water bath;

[0051] Step 4: Dry, crush and sieve to obtain solid powder.

[0052] Furthermore, 5 parts of milk thistle extract, 1 part of dihydromyricetin, and 10 parts of phospholipids.

[0053] Example 4

[0054] A method for preparing a milk thistle phospholipid complex comprises:

[0055] Step 1: dissolving milk thistle extract, dihydromyricetin and phospholipids in an organic solvent;

[0056] Step 2: Stir the solution system until the solution becomes clear;

[0057] Step 3: drying the clear solution under reduced pressure, and then adding phosphate buffer as a hydration medium for hydration in a water bath;

[0058] Step 4: Dry, crush and sieve to obtain solid powder.

[0059] Furthermore, 10 parts of milk thistle extract, 6 parts of dihydromyricetin, and 20 parts of phospholipids.

[0060] Example 5

[0061] A method for preparing a milk thistle phospholipid complex comprises:

[0062] Step 1: dissolving milk thistle extract, dihydromyricetin and phospholipids in an organic solvent;

[0063] Step 2: Stir the solution system until the solution becomes clear;

[0064] Step 3: drying the clear solution under reduced pressure, and then adding phosphate buffer as a hydration medium for hydration in a water bath;

[0065] Step 4: Dry, crush and sieve to obtain solid powder.

[0066] Furthermore, 8 parts of milk thistle extract, 5 parts of dihydromyricetin, and 15 parts of phospholipids.

[0067] Example 6

[0068] A method for preparing a milk thistle phospholipid complex comprises:

[0069] Step 1: dissolving milk thistle extract, dihydromyricetin and phospholipids in an organic solvent;

[0070] Step 2: Stir the solution system until the solution becomes clear;

[0071] Step 3: drying the clear solution under reduced pressure, and then adding phosphate buffer as a hydration medium for hydration in a water bath;

[0072] Step 4: Dry, crush and sieve to obtain solid powder.

[0073] Furthermore, 10 parts of milk thistle extract, 1 part of dihydromyricetin, and 20 parts of phospholipids.

[0074] Example 7

[0075] A method for preparing a milk thistle phospholipid complex comprises:

[0076] Step 1: dissolving milk thistle extract, dihydromyricetin and phospholipids in an organic solvent;

[0077] Step 2: Stir the solution system until the solution becomes clear;

[0078] Step 3: drying the clear solution under reduced pressure, and then adding phosphate buffer as a hydration medium for hydration in a water bath;

[0079] Step 4: Dry, crush and sieve to obtain solid powder.

[0080] Furthermore, 5 parts of milk thistle extract, 6 parts of dihydromyricetin, and 10 parts of phospholipids.

[0081] Example 8

[0082] A method for preparing a milk thistle phospholipid complex comprises:

[0083] Step 1: dissolving milk thistle extract, dihydromyricetin and phospholipids in an organic solvent;

[0084] Step 2: Stir the solution system until the solution becomes clear;

[0085] Step 3: drying the clear solution under reduced pressure, and then adding phosphate buffer as a hydration medium for hydration in a water bath;

[0086] Step 4: Dry, crush and sieve to obtain solid powder.

[0087] Furthermore, 5 parts of milk thistle extract, 6 parts of dihydromyricetin, and 15 parts of phospholipids.

[0088] Test Example 1

[0089] 1. Weigh 0.5000 g (accurate to 4 decimal places) of the sample of Example 1 into a 100 ml volumetric flask, add 90 ml of methanol, ultrasonicate for 25 min, take out and mix once every 10 min, let cool, dilute to the scale with methanol, shake well, let stand for 2 min, take the supernatant and pass it through a 0.45 μm microporous organic filter membrane, and then provide it for liquid chromatography determination. The result is Ct.

[0090] 2. Take 0.5000g (accurate to 4 decimal places) of Example 1 in a 10ml volumetric flask, add 9ml of chloroform, ultrasonicate for 25min, take out and mix once every 10min, let cool, add chloroform to dilute to the scale, mix, take 5ml and pass it through a 0.45μm microporous organic filter membrane, put it in a 100ml volumetric flask, add methanol to make up the volume, and then measure it on a liquid chromatograph. The result is Co.

[0091] 3. Chromatographic conditions refer to SN / T4002.2014.

[0092] 4. Compound rate calculation

[0093] complex rate=Co / Ct*100%.

[0094] Experimental group: 10 g of milk thistle, 17 g of phospholipids, 6 g of dihydromyricetin, 300 ml of anhydrous ethanol (the dosage is the same as that of Example 1)

[0095] At the same time, a control group was set up: 10g of milk thistle, 17g of phospholipids, and 300ml of anhydrous ethanol.

[0096] At the same time, the following table sets the test parameters of the stirring conditions

[0097] Table 1 Different stirring conditions

[0098]

[0099]

[0100] The other preparation steps are the same as those in Example 1: evaporating the organic solvent under reduced pressure, then hydrating in a water bath, followed by freeze drying and pulverizing.

[0101] Table 2 Recombination rate of control group and experimental group under different stirring conditions

[0102]

[0103] As shown in Table 2, the product recombination rate of the control group and the experimental group gradually increased with the increase of temperature and the extension of reaction time. At the same temperature and recombination time, the recombination rate of the experimental group was generally higher than that of the control group. This shows that the addition of dihydromyricetin promoted the recombination reaction of silybin and phospholipids, accelerated the recombination efficiency, and shortened the recombination time.

[0104] Test Example 2

[0105] (1) Prepare 2 groups of experiments with different material ratios:

[0106] Experimental group: 10 g of milk thistle, 17 g of phospholipids, 6 g of dihydromyricetin, 300 ml of anhydrous ethanol (the dosage is the same as that of Example 1)

[0107] At the same time, a control group was set up: 10g of milk thistle, 17g of phospholipids, and 300ml of anhydrous ethanol.

[0108] (2) Experimental plan:

[0109] Set the test parameters according to the table below and observe the time point when the solution becomes clear. The composite time is set to 2h

[0110] Table 3 Groups with different mixing and compounding time

[0111] Experimental groups Experimental parameters Experiment 1 30℃ Experiment 2 40℃ Experiment 3 50℃ Experiment 4 60℃ Experiment 5 80℃

[0112] Table 4 Solution clarification and recombination rate at different stirring and recombination times

[0113]

[0114]

[0115] Note: If the solution is not clear, the recombination rate is calculated based on the product obtained after 2 hours of recombination. If the solution is clear, the recombination rate is tested based on the product obtained when it is clear.

[0116] From the experimental results in Table 4, it can be seen that solution clarification is one of the important signs to judge whether the reaction is complete. The addition of dihydromyricetin promotes the complex reaction of silybin and phospholipids. From the process point of view, the reaction can be completed at a lower temperature and in a shorter time, reducing energy consumption and improving the utilization rate of organic solvents. From the efficacy point of view, the combination of silybin and dihydromyricetin and phospholipids significantly enhances the fat solubility and bioavailability, and the two work together to fully exert the liver protection effect.

[0117] It will be understood by those skilled in the art that, unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as generally understood by those skilled in the art in the art to which the present invention belongs. It should also be understood that terms such as those defined in general dictionaries should be understood to have meanings consistent with the meanings in the context of the prior art, and will not be interpreted with idealized or overly formal meanings unless specifically defined as herein.

[0118] It should be understood that the detailed description of the technical solutions of the present invention by means of the preferred embodiments is illustrative rather than restrictive. A person skilled in the art may modify the technical solutions described in the embodiments, or replace some of the technical features by equivalents, based on reading the specification of the present invention; and these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.

Claims

1. A method for preparing a silymarin phospholipid complex, It is characterized in that include: Step 1: Silybin, dihydromyricetin and phospholipids are dissolved in anhydrous ethanol; Step 2: Stir the solution system at 40-80°C until the solution becomes clear; Step 3: drying the clear solution under reduced pressure, and then adding phosphate buffer as a hydration medium for hydration in a water bath; Step 4: Dry, crush and sieve to obtain solid powder.

2. The method according to claim 1, It is characterized in that In the milk thistle phospholipid complex, the content of silybin is 2%-90%, and the content of dihydromyricetin is 2%-90%.

3. The method according to claim 1, It is characterized in that The raw materials include 5-10 parts of silybin, 1-6 parts of dihydromyricetin and 10-20 parts of phospholipids.

4. The method according to claim 1, It is characterized in that The amount of solvent is at least 5 times the total mass of the raw materials.

5. The method according to claim 1, It is characterized in that The reduced pressure drying temperature in step 3 is 20-70°C.

6. The method according to claim 1, It is characterized in that The conditions for water bath hydration are constant temperature water bath hydration and ultrasound to obtain a milky translucent liposome solution.

7. The silybum phospholipid complex prepared by the method for preparing the silybum phospholipid complex according to any one of claims 1 to 6, include: Silybin, dihydromyricetin and phospholipids, wherein the content of silybin is 2%-60%, and the content of dihydromyricetin is 2%-40%.

8. Use of a silymarin phospholipid complex in the preparation of a medicine for treating liver damage, the silymarin phospholipid complex being prepared by the method of any one of claims 1 to 6.

9. Use of a silymarin phospholipid complex in the preparation of liver-protecting medicines, dietary supplements and foods, the silymarin phospholipid complex being prepared by the method of any one of claims 1 to 6.

10. The use according to claim 9, It is characterized in that The food comprises health food.

Citation Information

Cited By

  • Composition containing soyabean lecithin and silybum marianum extract and application of composition in preparation of liver protection products

    CN121102302A